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Abstract
High coverage whole genome sequencing provides near complete information about genetic variation. However, other
technologies can be more efficient in some settings by (a) reducing redundant coverage within samples and (b) exploiting
patterns of genetic variation across samples. To characterize as many samples as possible, many genetic studies therefore
employ lower coverage sequencing or SNP array genotyping coupled to statistical imputation. To compare these
approaches individually and in conjunction, we developed a statistical framework to estimate genotypes jointly from
sequence reads, array intensities, and imputation. In European samples, we find similar sensitivity (89%) and specificity
(99.6%) from imputation with either 16sequencing or 1 M SNP arrays. Sensitivity is increased, particularly for low-frequency
polymorphisms (MAFv5%), when low coverage sequence reads are added to dense genome-wide SNP arrays — the
converse, however, is not true. At sites where sequence reads and array intensities produce different sample genotypes,
joint analysis reduces genotype errors and identifies novel error modes. Our joint framework informs the use of next-
generation sequencing in genome wide association studies and supports development of improved methods for genotype
calling.
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Introduction
High coverage whole genome sequencing gives maximum
information about individual-level genetic variation for use in
disease gene mapping [1–6] or population genetics [7–12].
However, due to cost limitations, most population-based studies
have estimated sample genome sequences through incomplete
data collection with SNP arrays [13,14], low coverage whole
genome sequencing [15,16], or high coverage targeted sequencing
[17–20]. To increase power, such studies often combine sample
genotypes with well-characterized public reference panels
[9,10,21] and use statistical imputation [22,23] to predict missing
or unassayed genotypes. It is as yet unclear how much power is
lost, and how much efficiency is gained, by these incomplete data
collection strategies.
The literature on analytical methods for low coverage
sequencing and SNP arrays has until now been largely non-
overlapping [14,24–29]. Past studies have investigated the power
and efficiency of each technology separately: how well subsets of
common variants [30–33] or commercially available SNP arrays
[34] ‘‘tag’’ common variants in the genome and empower
genome-wide association studies [35,36], the power of low
coverage sequencing relative to high coverage sequencing [37],
differences in performance of whole-genome sequencing technol-
ogies [38], and the performance of imputation [39] and its impact
on power [25,40,41]. As most investigators must decide among
these technologies, we sought to compare their power and
efficiency within a unified analytical framework. Moreover, as
genome wide association studies (GWAS) have been performed on
hundreds of thousands of valuable clinical samples, and as
investigators now must choose whether to collect additional data
on these samples with next-generation sequencing, we sought to
evaluate the benefit of combined sequence and SNP array data
collection strategies. Finally, we sought to exploit the existence of
sequencing and array data in a common set of samples to identify
error modes and thereby improve genotype calling algorithms.
Specifically, we asked four questions: (1) as a baseline, how does
power (sensitivity and specificity of genotype calls) vary based on
sequence read depth and SNP array density, with and without
imputation; (2) do combinations of different technologies have
improved performance relative to each data type alone; (3) when
sequencing and arrays disagree, is it possible to identify the
incorrect technology; and (4) can we learn and ultimately resolve
new error modes based on these disagreements?
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Results
We first developed a statistical framework that can jointly
estimate genotypes from array intensities, sequence reads, and
imputation (Figure 1). The framework first estimates genotype
likelihoods for each SNP independently from array intensities
and/or sequence reads and then combines these likelihoods to
produce joint likelihoods. The array genotype cluster locations
and the joint likelihoods are iteratively re-estimated using an
Expectation-Maximization algorithm with haplotype phasing and
imputation (Materials and Methods). In this manner, sequence
reads, intensities from SNP arrays, and haplotype phasing jointly
inform the genotype likelihood for each site in each individual
(Figure S1). We developed an implementation of this framework
that uses published methods for SNP array clustering [14],
sequence SNP calling [27], and imputation [42] to call sample
genotypes (Figure S2); source code is available from the authors
upon request.
This framework produces an integrated estimate of the
sequence variation in each individual, enabling comparisons
among technologies. We used it to perform a series of experiments,
modeling different array or sequence data collection strategies.
Using raw array intensities and sequence reads from the Hapmap
[9,21] and 1000 Genomes (1000 G) projects [10], we evaluated six
SNP arrays (five genome-wide with 100 k to 2.5 M SNPs, one the
custom Metabochip), four levels of whole-genome Illumina
sequence coverage (.56 - 46reads per base), and all combinations
thereof. In each analysis we called genotypes on chromosome 20
for 382 unrelated European samples from phase 1 of the 1000 G
Project. In our primary analysis, we only called genotypes with
posterior probability above 90%; the remainder were considered
missing (no-calls). In addition, the current experiments evaluate
SNPs only (i.e. they do not consider insertions, deletions, or
structural variation) and are limited to autosomal chromosomes.
Full details of our experimental setup are given in Materials and
Methods; analysis of the impact of different parameters, such as
the number and ethnicity of samples genotyped, is provided in
Text S1.
To evaluate performance (relative to high coverage whole
genome sequencing), we compared the resulting genotype calls for
a single test sample to ‘‘gold-standard’’ genotypes, published from
multiple high coverage sequencing technologies by the 1000
Project Pilot, for the same sample. We focused our metrics only on
non-reference alleles. To measure sensitivity (how well a strategy
identifies all true non-reference alleles) we defined SensDirect
(SensD) and SensImputation (SensI) as the fraction of non-reference
gold-standard genotypes with identical called genotypes (without
and with imputation respectively). Conversely, to measure
specificity (how well a strategy identifies only true non-reference
alleles), we defined SpecDirect (SpecD) and SpecImputation (SpecI) as
the fraction of non-reference called genotypes with identical gold-
standard genotypes (without and with imputation). Further details
of our experimental procedure are given in Materials and Methods
and Figure S3.
Evaluation of sensitivity and specificity
We first assessed the sensitivity of each technology. Figure 2a
and Figures S4, S5, S6, S7, S8, S9 show that values of SensD vary
widely, increasing roughly linearly with array density from 1.7% to
Figure 1. A statistical framework for joint genotype calls. We
developed a statistical framework to jointly estimate sample genotypes
from array intensities, sequence reads, and haplotype phasing. The
framework first estimates genotype likelihoods independently for each
SNP from array and sequence data, given initial parameters for
genotype cluster locations and sequence read error rates. It then
multiplies the likelihoods for each SNP to obtain joint likelihoods, inputs
these to haplotype phasing and imputation, and then uses the output
likelihoods to re-cluster intensities for all SNPs. The process is iterated,
and upon termination genotype likelihoods are converted to posterior
genotype probabilities. The framework can estimate genotypes given
only sequence data or array data as well as with or without imputation
— many of these special cases are similar in principle to previously
described genotyping algorithms (Text S1).
doi:10.1371/journal.pcbi.1002604.g001
Author Summary
In this work we address a series of questions prompted by
the rise of next-generation sequencing as a data collection
strategy for genetic studies. How does low coverage
sequencing compare to traditional microarray based
genotyping? Do studies increase sensitivity by collecting
both sequencing and array data? What can we learn about
technology error modes based on analysis of SNPs for
which sequence and array data disagree? To answer these
questions, we developed a statistical framework to
estimate genotypes from sequence reads, array intensities,
and imputation. Through experiments with intensity and
read data from the Hapmap and 1000 Genomes (1000 G)
Projects, we show that 1 M SNP arrays used for genome
wide association studies perform similarly to 16 sequenc-
ing. We find that adding low coverage sequence reads to
dense array data significantly increases rare variant
sensitivity, but adding dense array data to low coverage
sequencing has only a small impact. Finally, we describe an
improved SNP calling algorithm used in the 1000 G
project, inspired by a novel next-generation sequencing
error mode identified through analysis of disputed SNPs.
These results inform the use of next-generation sequenc-
ing in genetic studies and model an approach to further
improve genotype calling methods.
Efficiency and Power of Genotyping Strategies
PLoS Computational Biology | www.ploscompbiol.org 2 July 2012 | Volume 8 | Issue 7 | e1002604
31.51% (r2~:948) and roughly linearly with sequence coverage
from 4.55% to 61.34% (r2~:999). However, SensI values are
dramatically higher than, and increase less steeply with, density
and coverage (26–92% for arrays, 84%–95% for low coverage
sequencing). Strikingly, even low depths of sequence coverage
(0.56) provide high values for SensI (83.33%). These results reflect
that most genetic variation in any given European individual is
common and redundant due to LD, and such variation is
extracted effectively using imputation with access to data from
the 1000 G Project.
Based on the clear value and wide availability of methods and
data for statistical imputation, from this point forward we discuss
only calls made using imputation.
We next assessed the specificity of each technology. Using a
90% posterior probability no-call threshold, SpecI values are
above 99% for almost all assays. Completely eliminating the no-
call threshold increases SensI substantially but at the cost of SpecI
decreased to &98% (Figures S10, S11). While overall specificity
remains high, the specificity of marginal calls added due to the
reduced threshold is lower (&95%). Based on individual aims,
investigators must thus choose posterior probability thresholds to
trade off sensitivity for specificity.
Our analysis allowed direct comparison of low coverage
sequencing and SNP arrays within a common framework
(Figure 2ab). For example, we find that 0.56 sequence coverage
is more sensitive than 500 k SNP arrays (84% vs. 70% SensI), that
16 sequencing is comparable to a 1 M SNP array (89% SensI),
and that 26 sequencing is similar to 2.5 M SNP arrays (93% vs.
92% SensI). Although all technologies have higher sensitivity for
variants with non-reference homozygous genotypes than at
variants with heterozygous genotypes, the relative sensitivities of
the technologies are roughly the same for both variant classes
(Figure S12). Thus, sequencing to one-half or one-quarter of
coverage previously proposed for complex trait association studies
[37] gives comparable sensitivity to SNP arrays used successfully
for GWAS.
Figure 2. Sensitivity and specificity of data collection strategies. For different combinations of array and sequence data, we produced joint
genotype calls on chromosome 20 for 382 European samples from the 1000G project. For a single test sample, we obtained ‘‘gold-standard’’
genotypes from high coverage multi-technology sequencing published by the 1000G project. We then measured non-reference site sensitivity and
specificity with imputation (SensI, SpecI) and without (SensD, SpecD). (a) SensD (left) and SensI (right) of calls from five array densities and four
sequence coverages. The first row of each table contains results for strategies with only sequence data, and the first column contains results for
strategies with only array data. A common color scheme is used across all tables, with white corresponding to 100%, red corresponding to v20%,
and yellow corresponding to 80%. (b) SpecI of calls; SpecD is given in Figure S9. (c) SensI for three variant frequency ranges, with frequency
estimated from the non-test samples. Private variants have frequency 0% in the non-test samples. (d) SensI for four sequence coverages, with
separate lines that correspond to joint calls made with each SNP array. (e) SensI for four array densities, with separate lines that correspond to joint
calls made with each sequence coverage. No Array: from sequence data alone; 06: from array data alone; .56-46: mean number of sequence reads
per genomic position; array abbreviations are defined in Materials and Methods.
doi:10.1371/journal.pcbi.1002604.g002
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Notably, performance is different for coding variants — which
constitute v1% of variant sites in our test sample but are a high
priority for some genetic studies [5]. In this setting, w1M SNP
arrays and 46 sequencing have significantly higher sensitivities for
coding variants relative to noncoding variants (Figure S13). In
contrast, v1M arrays arrays or ƒ2x sequencing have slightly
lower sensitivities for coding variants relative to noncoding
variants. As a result, for coding variants alone, 26 sequencing
(in contrast to 16 sequencing) is comparable to a 1 M SNP array.
We observe that different methods, even those with similar
sensitivities across all variants, perform differently across the
frequency spectrum (Figure 2c, Figure S14). In particular, for low
frequency polymorphisms (MAF .5-5%), low coverage sequencing
far outperforms current SNP arrays after imputation with v400
European samples. For example, 16 coverage provides similar
SensI (&70%) and SpecI (99.5%) to the densest current arrays
(2.5 M SNPs), and 46coverage far outperforms both (SensI 86%,
SpecI 99.5%).
Based on the different sensitivities of SNP arrays and sequencing
across the frequency spectrum, we asked if calls made jointly from
the two technologies might have higher sensitivity and specificity
than calls from either technology alone. We find that, regardless of
the array density or sequence coverage, joint calls uniformly have
higher SensI and SpecI than calls made using only a single
technology. However, for any allele frequency, the effect of added
array data is exceedingly small once sequence coverage is 26 or
greater (Figure 2d). In contrast, addition of sequencing data to first
generation (500 k) arrays has substantial benefits across the entire
allele frequency spectrum, and even addition to the densest
current arrays (2.5 M) substantially increases performance at sites
with minor allele frequency v5% (Figure 2d).
These results are particularly relevant in light of the hundreds
of thousands of samples previously characterized using first
generation SNP arrays for GWAS [43]. As compared to
additional higher density genome-wide array-based genotyping,
low coverage whole genome sequencing appears to result in
greater improvement in sensitivity and specificity per individual
(post imputation; Figure 3, Figure S15). The performance
increase is greatest for low frequency polymorphisms, a high
priority target for many post-GWAS experiments [43–47]. We
note, however, that our metrics do not measure how many
samples have genotype calls at each variant site — arrays
genotype each sample at the same set of sites, while low coverage
sequencing may genotype each sample at a slightly different set of
sites. For some studies, the benefit of having a uniform set of sites
genotyped may outweigh the higher per-sample sensitivity of low
coverage sequencing.
Analysis of SNP array and sequencing error modes
In addition to increased sensitivity, joint analysis of low
coverage sequencing and array data in the same samples can
identify technology-specific error modes at the small number of
sites with disputed genotypes. Such analysis can reduce genotype
errors in these samples, through resolution of these disputes, but
Figure 3. Data collection strategies for studies with prior array data. For the (a) Affy 6 and (b) Ilmn 1 M arrays, we produced joint calls after
addition of each sequence coverage orw1m array; joint calls with multiple arrays include combined data from both arrays. The y-axis shows SensI ,
while the x-axis shows SensD of the additional data collected. SensD is a measure of the genotyping investment intrinsic to a technology that serves
as a proxy for cost. The blue point (None) shows SensI if no additional data is collected; the other points are labeled with the additional data
collected. Labels are defined in 2.
doi:10.1371/journal.pcbi.1002604.g003
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more importantly can spur development of improved genotyping
algorithms for each technology.
We first asked if two specific error modes were resolved by joint
calls. First, we examined sites where low coverage sequencing
provided insufficient data to confidently call genotypes post
imputation. We hypothesized that joint calls, made with addition
of a high density SNP array, might significantly improve sensitivity
at these sites by providing high quality genotypes to better identify
haplotypes and inform imputation. We observe that joint calls do
have higher SensI than calls from low coverage sequencing alone
(Figure 2a), particularly for the lowest sequence coverages
considered (.56 and 16). However, the improvement in imputa-
tion quality is minimal when sequence coverage is§2x— evinced
by almost undetectably larger joint call SensI values at sites absent
from the array, where any increases are due solely to improved
imputation (Figure 4a, Figure S16).
We also examined sites where SNP arrays produce incorrect
genotype calls due to erroneous or poorly resolved genotype
cluster locations. We hypothesized that joint calls, informed within
our framework by low coverage sequencing data in the same
samples, might increase sensitivity through improved cluster
locations. Our results show that joint calls do reduce incorrect
genotype calls, with up to 75{90% reductions in false negatives
(1{SensI, Figure 4b, Figure S17) across all minor allele
frequencies (Figures S18). As previously reported, haplotype
phasing [25] further increases sensitivity (Figure 4b, Figure S19).
Thus, joint calls do reduce genotype errors due to improved
cluster locations, although we also find that additional sequence
data on the test sample has a significant impact (Figure S20).
To identify additional error modes, we searched for SNPs at
which array data frequently disagreed with 46 sequencing data
(§10% of samples with different genotypes). On the Metabochip
— a custom array with many low frequency or unvalidated SNPs
— we identified 3,262 such disputes. Analysis of these SNPs
revealed two error modes that suggested altered analytical
procedures for array or sequence genotyping.
First, 639 SNPs were called polymorphic in analysis of sequence
data but monomorphic in analysis of the same samples on the
Metabochip. In sequencing studies that genotype SNPs called
from sequence data on a custom array and require polymorphic
array genotypes to ‘‘validate’’ SNPs, these 639 SNPs would be
flagged as false-positives in the original sequence-based discovery.
Figure 4. Reduction in errors from joint genotype calls. (a) To assess the improvement in imputation quality afforded by joint genotype calls
with a SNP array (relative to calls based on sequence data alone), we measured sensitivity and specificity at sites absent from the array; errors at these
sites can be reduced only through improved imputation. The Metabochip is absent from this plot, as it is not a genome-wide array. Plotted are
1{SensI and 1{SpecI, the sum of which equals the number of sites where (1) the gold-standard or called genotype is non-reference and (2) the
gold-standard and called genotypes disagree. Normalized values (defined in Materials and Methods) are plotted to show visual trends; actual values
are given in Figure S16(b) To assess the reduction in erroneous genotype cluster locations afforded by joint genotype calls with sequence data
(relative to calls based on array data alone), we measured sensitivity and specificity at sites on the array. Red bars correspond to SpecD and SensD,
measured from calls without haplotype phasing; blue bars correspond to SpecI and SensI , measured from joint calls. As described in Materials and
Methods, these experiments used 82 additional unrelated samples, absent from our other experiments, to inform cluster locations.
doi:10.1371/journal.pcbi.1002604.g004
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However, joint calls of these 639 SNPs predict that 331 are
actually polymorphic, while only 181 are monomorphic (127 are
no-calls; Figure S21). Joint calls thus partially address false-
negative genotype calls, a known SNP array error mode [21].
Second, through visual examination of a number of disputed
SNPs, we identified a recurrent sequencing error mode caused by
PCR errors in the library preparation stage of next-generation
sequencing [48] (Figure 5ab). Specifically, overlapping paired-end
reads both reflect the same PCR error, and assumed independence
of the read error rates leads to over-confident non-reference
genotype calls (Figure 5c). This error mode is increasingly common
given the growing length of sequencing reads (&100 bp and up)
relative to standard library sizes (&200{400 bp). Based on this
observation, we developed a new sequence genotype likelihood
calculation that properly accounts the dependency of overlapping
read pairs from the same DNA fragment. Briefly, the new method
models errors at the fragment construction stage separately from
errors during the sequencing stage, and it thus counts fragment
errors only once for each read pair. (Figure S22a). Experiments
showed that this new method improves both sequence genotyping
accuracy and SNP site discovery (Figure 5d, Figure S22b); as a
result, it has been incorporated into the Unified Genotyper of the
Genome Analysis Toolkit (GATK) [27] and applied to many
sequencing experiments including the production phase of the
1000 G Project.
Given the improvements that followed discovery of this novel
sequencing error mode, further analysis of disputed SNPs might
suggest additional unrecognized error modes and additional
improvements to genotyping algorithms. When gold-standard
genotypes are unavailable to serve as a filter between array and
sequence errors, joint calls can serve as a proxy — of the disputed
SNPs on Metabochip for which our test sample genotype is in
disagreement, 85.7% of joint calls are consistent with gold-
standard genotypes. Filtering SNPs with joint calls that closely
match calls from sequence data as apparent array errors, and the
remainder as apparent sequence errors (Figure S23a), classifies
70.5% of the disputed SNPs on the Metabochip as apparent
sequence errors. Based on tests of enrichment for 18 potential
error modes, this filtration strategy does in fact produce two
distinct classes of SNPs: apparent array errors are enriched for
DNA flanking regions of low complexity and flanking regions that
occur multiple times in the genome (Figure S23b; Figures S24,
S25), while apparent sequence errors are enriched for properties
such as DNA strand bias or flanking homopolymer runs (Figure
S23c). However, given that only 61% of the apparent array errors
and 49% of the apparent sequence errors are characterized by one
of the potential error modes we considered (Figure S26), analysis
of the remaining SNPs may provide a rich source of novel error
modes.
Discussion
While high coverage sequencing remains the most accurate
genotyping technology available, combinations of less compre-
hensive technologies can increase study efficiency and enable more
samples to be genotyped. To this end, we developed a statistical
framework that combines data from sequencing and array-based
genotyping platforms, as well as imputation, to produce an
integrated estimate of genetic variation within each individual. In
this study we applied the framework to quantify the efficiency and
power of strategies for data collection that include one or both of
these technologies. As the pace of sequencing or other genotyping
technology development quickens [48,49], this work provides a
foundation to call genotypes for samples analyzed on one or more
new technologies — particularly those samples with prior data
already available.
Our experiments with this framework measure the number of
variant sites assayed in a single European individual and closely
model the scenario where 1000 G Project data is used as a
reference panel for imputation. The strategies we considered will
likely assay fewer variant sites in non-European ethnicities,
particularly those with less complete reference panels available
(Text S1). The SensI and SensD metrics we used in our
experiments also have limitations. In some cases the total number
of variant sites assayed across all individuals, a metric influenced
far more by rarer variants, may be more relevant; no strategy we
considered is a good assay of very rare or private variants
(MAFv:5%), which are the focus of diagnostic studies [5].
Another relevant metric might be the power to associate disease
alleles, which is influenced not only by sensitivity and specificity
but by the total study size, the number of samples genotyped at
each disease allele, and the disease architecture [35]. Further work
is needed to fully understand the performance of each data
collection strategy under these alternate metrics. Further work is
also needed to quantify the ability of each strategy to assay small
insertions or deletions [50] as well as larger structural variants
[51,52], which our experiments do not directly measure.
In addition, our experiments provide a snapshot in time of the
quantitative performance of each strategy. As technologies
improve and reference panel sizes increase, the absolute and
relative values of our metrics will change. Higher sequence
coverage or improved algorithms for read mapping and variant
calling, which occur continuously, would increase sequencing
performance relative to SNP arrays — not only through increased
coverage but also through increased imputation performance due
to fewer genotyping errors. Reduction in the already small error
rates for SNP arrays will improve sensitivity and specificity only
slightly, implying that the relatively slower increase in array
density will offer the most significant improvements in array
performance. Larger reference panels, which will soon have more
than ten times as many samples as the reference panel used in our
experiments, will improve the performance of all strategies — for
lower frequency variants in particular.
Nonetheless, our results suggest that, for studies that character-
ize European samples and use the 1000 G reference panel for
imputation, low coverage 16 sequencing assays a similar number
of sites in each individual as the 1 M SNP arrays used for GWAS,
while 26 sequencing out-performs even the highest density arrays
currently available. This confirms low coverage sequencing,
although of depth even lower than previously suggested or used
[10,37], as an attractive genotyping strategy relative to SNP arrays
for samples characterized de novo. Based on the approximately
2.75 M non-reference genotypes in our European test sample, our
metrics translate to about 300 k false negative and 15 k false
positive genotypes per genome for 16 sequencing or 1 M SNP
arrays, 200 k false negative and 8 k false positive genotypes for 26
sequencing, and 100 k false negative and 4.5 k false positive
genotypes for 46 sequencing with a 2.5 M SNP array.
For studies with samples previously genotyped on genome-wide
SNP arrays, addition of low coverage sequencing substantially
improves performance — for lower frequency sites in particular.
As a result, addition of 16or even .56sequence coverage provides
more novel information than additional dense genome-wide array-
based genotyping.
At the small number of sites where sequencing and array
genotypes disagree, joint calls significantly reduce error rates.
Array genotype errors due to incorrect or poorly resolved
genotype cluster locations are reduced by as much as 75–90%.
Efficiency and Power of Genotyping Strategies
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Figure 5. A novel next-generation sequencing error mode. (a) We identified a novel error mode based on visual examination of disputed
SNPs. As shown in the cluster plot, one of the samples is called homozygous reference (Hom-ref) based on analysis of array data but homozygote
non-reference (Hom-var) based on analysis of sequence data (shown by the sample outlined in green within the red cluster). This unusual error mode
contrasts with the more common error mode, due to low sequence coverage, of samples called heterozygous (Het) based on array data but
homozygous reference or non-reference based on sequence data (shown by samples outlined in pink or green within the blue cluster). (b) Inspection
of the sequence reads in the Integrated Genomics Viewer (IGV) [54] shows that the sample in question has only two reads that cover this SNP, and
these reads are pairs sequenced from the same underlying DNA fragment. (c) This error mode is introduced in the shearing and library preparation
stage of next-generation sequencing and as a result is reflected in both reads from the same DNA fragment. Depending on protocol details, the error
rate is around 1/10,000. During genotype calling, independent treatment of reads (read-based) results in much more confident (here 1006) non-
reference genotype calls than analysis at the fragment level (fragment-based). (d) To account for these effects, which can be large for low coverage
sequencing projects like the 1000G Project, we implemented a fragment based genotyping algorithm in the Unified Genotyper of the Genome
Analysis Toolkit (GATK). Use of this new caller has a significant impact on SNP call quality, shown by a smaller number of novel SNP calls and a higher
Transition:Transversion ratio (proxies for accuracy [27]). The effect is pronounced for populations such as MXL and ASW, which have a higher fraction
of newer Illumina sequencing data with longer reads (e.g., AWS data is&75%w76bp reads, while YRI has less than&25%), which results in greatly
increased rate of overlapping reads and associated errors. Abbreviations are as defined in the 1000G Project.
doi:10.1371/journal.pcbi.1002604.g005
Efficiency and Power of Genotyping Strategies
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In contrast, sequence genotype errors due to poor imputation are
also reduced but only by only a small amount.
Two error modes identified through analysis of disputed SNPs
illustrate how our framework can suggest paths to improve
technology-specific genotype calling algorithms. SNPs called
monomorphic on a custom array may be false negatives of the
array — sequencing false positive rates need thus be assessed
through joint data analysis, rather than through use of array data
as gold-standard. As another example, a novel class of sequencing
errors inspired development of a sequence genotyping method that
has improved SNP discovery and genotyping accuracy in the
production phase of the 1000 G project.
At present, a framework for joint genotype estimation facilitates
study design and reduces genotype errors. In the future, as
hundreds of thousands of valuable samples already genotyped on
genome-wide SNP arrays are targeted for further genotyping, we
suggest that joint calls may be the most informative analytical
strategy. At a minimum, such frameworks provide a principled
approach to compare and combine the wider variety of data types
that will inevitably be developed.
Materials and Methods
A statistical framework for joint genotype calls
We developed a statistical framework to compute genotypes for
N total samples at M total biallelic SNPs, given intensity data I
and sequence data S. Imn and S
m
n represent data for sample n and
SNP m, In and Sn represent data for all SNPs for sample n, and I
m
and Sm represent data for all samples for SNP m; missing values
are allowed for any Imn or S
m
n . For each sample n and SNP m, we
estimate Pr Gmn DI,S
 
, the posterior probability of the three
genotypes, conditional upon intensity and sequence data for all
samples and all SNPs.
The framework uses a naive Bayes model for sequence and
intensity data — that is, Smn and I
m
n are conditionally independent
given Gmn . Thus, dependencies — between sequence and intensity
data, across samples, or across SNPs — occur only because true
genotypes are unknown. Values for Imn are 2-vectors that
correspond to probe intensities for the two alleles of SNP m in
sample n; they are modeled under a mixture of 2-dimensional
normal distributions, with a different mean (m), covariance (S), and
prior probability (p) for each of the three genotype classes. The
intensity model is thus
Pr(Imn ; p
m,mm,Sm)~
X3
i~1
pmi f I
m
n ; m
m
i ,S
m
i
 
,
where f is the two-dimensional normal distribution. Sequence
data is not modeled directly and is assumed to depend on
parameters estimable without sample genotype knowledge. To
allow any model for Smn that satisfies this requirement, the
framework accepts likelihood values L Gmn ;S
m
n
 
~Pr Smn DG
m
n
 
as
input.
To call genotypes, the framework aims to maximize
L m,
X
,p;S,I
 
~Pr S,IDm,
X
,p
 
~
X
G
Pr S,I,GDm,
X
,p
 
,
the likelihood of all parameters given observed sequence and
intensity data for all samples and all SNPs. It employs an
Expectation-Maximization (EM) algorithm which proceeds in
iterations [53].
Initialization. Initial values for hm(1): mm(1),Sm(1),pm(1)
 
are
estimated for each SNP. We implemented this step with the
Birdseed algorithm [14], which estimates parameters separately
for each SNP given intensity data.
E-step. Given current values of hm(t): pm(t),mm(t),Sm(t)
 
, the
E-step computes
Q(hmDhm(t))~E
GDS,I;hm(t) log L h
m;S,I,Gð Þ½  ð1Þ
~
X
n
X3
i~1
Pr Gmn~iDS,I; h
m(t)
 
log pmi zlog f I
m
n ; m
m
i ,S
m
i
  
, ð2Þ
which requires estimates of Pr GDS,I; hm(t)
 
. To obtain these
estimates for each SNP, we first compute
Pr Smn ,I
m
n DG
m
n ; p
m,mm,Sm
 
~Pr Imn DG
m
n ; p
m,mm,Sm
 
|Pr Smn DG
m
n
 
,
where values for Pr Imn DG
m
n ; p
m,mm,Sm
 
are given by the normal
distribution density function, and values for Pr Smn DG
m
n
 
are given
as input and remain constant throughout the algorithm by
assumption. To estimate Pr GDS,I; hm(t)
 
then requires a haplotype
phasing and imputation algorithm, because Pr Gmn DS,I; h
m(t)
 
=
Pr Gmn DS
m,Im; hm(t)
 
due to LD relationships between nearby SNPs.
We implemented the phasing and imputation step with 20 iterations
of the Beagle 3.3.0 algorithm [42], which accepts genotype
likelihoods Pr S,IDG; hm(t)
 
as input and calculates values of
Pr Gmn DS,I; h
m(t)
 
as output.
M-step. The parameters mm, Sm, and pm are updated
through maximization of the equation that results from the E-step:
hm(tz1)~ arg max
hm
Q hmDhm(t)
 
,
which yields
pm(tz1)~
1
N
XN
n~1
Pr Gmn jS,I
 
m
m(tz1)
i ~
PN
n~1 Pr G
m
n~ijS,I
 
ImnPN
n~1 Pr G
m
n~ijS,I
 
Sm(tz1)i ~
PN
n~1 Pr G
m
n~ijS,I
 
Imn {m
m(tz1)
i
 
Imn {m
m(tz1)
i
 T
PN
n~1 Pr G
m
n~ijS,I
 
The E-step and M-step are iterated multiple times, and, upon
termination, final values of Pr Gmn DS,I
 
are returned as genotype
calls. We used three iterations to obtain our experimental results.
We did not explore the value of additional iterations, but we
expect genotype accuracy to improve with additional iterations at
the cost of added computational burden.
Experimental data and procedure
For our experiments, we used our framework to call joint
genotypes for combinations of intensity and read data from the
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Hapmap [9,21] and 1000 G [10] projects (Figure S3). We tested
five different density genome-wide SNP chips — the Affymetrix
100 K (Affy 100 k; 116,199 SNPs) and 500 K (Affy 500 k;
500,668 SNPs) GeneChip Mapping Sets, the Affymetrix Genome-
Wide Human SNP Array 6.0 (Affy 6; 906,600 SNPs), the Illumina
Human1M-Duo (Ilmn 1 M; 1,199,187 SNPs), and the Illumina
HumanOmni2.5–8 (Omni 2.5, 2,450,000 SNPs) — one custom
SNP chip — the Illumina Cardio-Metabo Chip (Metabochip;
196,725 SNPs) — and four different levels of whole-genome
sequence coverage — an average of one-half (.56), one (16), two
(26), and four (46) reads aligned to each base in the genome.
Intensity data for the Affy 100 k and Affy 500 k arrays were
downloaded from the International Hapmap Project website
(http://hapmap.ncbi.nlm.nih.gov) and formatted for input with
the Affymetrix Power Tools (APT) Software Package. To obtain
intensity data for the Affy 6, Ilmn 1 M, Omni 2.5, and
Metabochip arrays, we genotyped 180 Hapmap samples on each
array using standard lab protocols; for the Omni 2.5 array, we also
genotyped an additional 381 European samples from the 1000 G
June 2011 Integrated Phase 1 Variant Release. For the Illumina
arrays, raw data (in the form of IDAT files) was converted to
normalized intensity data using a custom implementation
IDATConverter of the Illumina normalization algorithm (algo-
rithm details kindly provided by Illumina). Illumina normalized
intensity data were then scaled by a factor of 2000 to be within the
range expected for Birdseed allele intensity input files. Affymetrix
raw intensity data were normalized with the quantile normaliza-
tion method in the APT program apt-probeset-summarize.
Sequence data for the 180 Hapmap samples were downloaded
from the 1000 genomes project Pilot 1 release, and data for the
381 European samples were downloaded from the Integrated
Phase 1 Variant Release (http://www.1000genomes.org). Se-
quence data for each sample was roughly 46 coverage, and to
approximate .56, 16, or 26 coverage, was down-sampled with
the GATK [27] to randomly keep 12.5%, 25%, or 50% of the
sequence reads.
We downloaded sequence and genotype data for our test sample
(Hapmap sample NA12878) from the 1000 G Pilot 2 release. The
genotype data was used as gold-standard data. We used the
sequence data to approximate 46coverage for our test sample: we
kept reads from a sufficient number of read groups such that the
average depth was as close as possible to 46 genome-wide, with
read groups preferentially chosen to include those with the latest
sequencing technology. We then further down-sampled this data
with the GATK to approximate .56 (12.5%), 16 (25%), or 26
(50%) sequence coverage for our test sample.
Sequence likelihoods Pr SDGð Þ input to the joint calling
framework were obtained from the downloaded or down-sampled
sequence data with the Unified Genotyper (UG) module of the
GATK. We ran the UG with its default arguments.
For each experiment, we jointly called genotypes for our test
sample together with the 381 European samples. For all
experiments we used 46 sequence coverage and Omni 2.5
intensity data for the 381 samples, while we varied the sequence
and intensity data used for the test sample.
Because only our test sample had intensity data for the Affy
100 k, Affy 500 k, Affy 6, or Ilmn 1 M arrays, we needed to use
additional samples to learn cluster locations for experiments with
these arrays (a single sample cannot be clustered). These additional
samples were 41 unrelated European and 41 unrelated African
samples from among the 180 Hapmap samples genotyped on the
arrays. For experiments that solely evaluated calls at sites on each
array, we used joint calls from these 82 samples together with our
test sample. For experiments that evaluated overall sensitivity and
specificity, we used these 82 samples to obtain cluster locations
that we then input to the joint calling framework.
Sensitivity and specificity were computed for each experiment
as described in the main text. We report numbers computed only
from SNPs on chromosome 20. We also omitted A/T or G/C
SNPs when we computed our metrics to avoid possible DNA
strand ambiguities.
Normalized SensI and SpecI
For our analysis of the improvement in imputation due to joint
calls with array data, we analyzed SensI and SpecI at sites absent
from the array. Because each array contains a different set of sites,
different SNPs were used to compute metrics for each array.
Therefore, to show visual trends for this analysis, we plotted
normalized rather than raw values of 1{SensI or 1{SpecI.
Normalized values are computed separately for each sequence
coverage in three steps. First, raw joint call values (SensI or SpecI)
are computed for each array at sites absent from the array. These
values are then divided by the corresponding value for calls from
sequence data alone, computed at the same set of sites. Finally,
these values are scaled by the corresponding value for calls from
sequence data alone, computed over all sites. Actual values of
1{SensI or 1{SpecI are given in Figure S16.
Statistical analysis of discordant SNPs
We defined 18 potential error modes (5 binary, 13 continuous)
and tested whether apparent sequence errors or apparent array
errors were enriched for each. For the 5 binary error modes, we
computed the fraction of apparent sequence errors and apparent
array errors with the error mode and then assessed differences
between the groups with Fisher’s exact test; for the 13 continuous
error modes, we used a Kruskal-Wallis one-way analysis of
variance to test for differences between the apparent sequence
error and apparent array error distributions. Nominally significant
p-values (Pv:05) resulting from the test were taken as evidence
that either apparent sequence errors or apparent array errors were
enriched for the error mode.
To identify novel error modes, we filtered our apparent
sequence errors and apparent array errors that were characterized
by an error mode. We used one of two procedures for this; the goal
was to flag disputes that could potentially (although not
necessarily) be caused by an error mode. We considered a SNP
as characterized by a binary error mode (value 0 or 1) if it had
value 1 for the error mode. For continuous error modes, we used
kernel density estimation as implemented in the R software
package to fit separate probability density functions to SNPs not in
dispute (fc), apparent sequence errors (fs), and apparent array
errors (fa). We then considered a SNP with value v for the error
mode as characterized if
L~log10
f (v)
fc(v)
 	
§2,
with f~fs for apparent sequence errors and f~fa for apparent
array errors.
Supporting Information
Figure S1 Sequence data and haplotype phasing inform
SNP array cluster locations. Our joint calling framework uses
an iterative algorithm to estimate genotypes from sequence reads,
SNP array intensities, and imputation. To call genotypes from
intensity data requires estimation of cluster locations — the
expected distribution of intensities given each genotype — which
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can be challenging for SNPs with low population frequencies or
cluster locations that differ from prior expectations. Our
framework estimates cluster locations conditional on not only
SNP array intensity data, as do many array clustering algorithms,
but also on sequence data and linkage disequilibrium relationships
with nearby SNPs. As shown for this illustrative SNP, as more data
informs the joint calls, the cluster locations typically improve. Each
circle represents a sample, and the two axes represent probe
intensities for each allele. Red, blue, and green colors correspond
to the three genotypes (gray or black indicates no-calls): ovals
represent cluster locations based on array calls, the outline of each
circle represents the sequence calls, and the fill of each circle
represents the joint call. (a) Cluster locations given only array data;
no genotypes can be called. (b) Genotypes given only sequence
data; most genotypes can be weakly called. (c) Genotypes obtained
by multiplying SNP array and sequence genotype likelihoods;
some genotypes can be called but the cluster locations do not
change. (d) Genotypes given sequence and array data for this SNP
only; most genotypes can be called and cluster locations begin to
resolve. (e) Genotypes given sequence and array data for all SNPs;
all genotypes can be called and cluster locations mostly resolve.
(PDF)
Figure S2 Algorithm overview. We implemented our
framework in a Python program. The program accepts a set of
partially overlapping intensity files, with SNP array data, and VCF
files, with sequence genotype likelihoods. It initializes cluster
locations and sample genotypes using the Birdseed algorithm, and
then iteratively re-estimates sample genotypes and cluster
locations. It uses the Beagle algorithm for phasing and imputation
and a modified version of Birdseed to estimate cluster locations
conditional on current genotype estimates, intensity data, and
sequence data. After a number of iterations, the program produces
a VCF file with posterior probabilities of all genotypes for all input
samples at all input sites.
(PDF)
Figure S3 Experimental procedure. Schematic of the
procedure used for our experiments. Details are given in Materials
and Methods.
(PDF)
Figure S4 Sensitivity and specificity of data collection
strategies: 41 sample European reference panel. Shown is
data analogous to Figure 2 but for a 42 European samples rather
than 382 samples. As described in Text S1, this closely models the
use of a 41 European sample reference panel for imputation (just
as our main experiments closely model the use of a 381 European
sample reference panel). While the test sample remains the same as
in Figure 2, we used different sequence data for this experiment —
therefore, the SensD values differ. (a) Sensitivity of calls. (b)
Specificity of calls. (c) SensI by variant frequency. (d) SensI for
four sequence coverages. (e) SensI for four array densities.
(PDF)
Figure S5 Sensitivity and specificity of data collection
strategies: 41 sample African reference panel. Shown is
data analogous to Figure S4 but for an African reference panel
rather than a European reference panel. (a) Sensitivity of calls. (b)
Specificity of calls. (c) SensI by variant frequency. (d) SensI for
four sequence coverages. (e) SensI for four array densities.
(PDF)
Figure S6 Sensitivity and specificity of data collection
strategies: no reference panel. Shown is data analogous to
Figures S4, S5 but absent a reference panel — all samples were
sequenced to the depth and genotyped on the array referenced in
the table. (a) 42 European samples sequenced. (b) 42 African
samples sequenced.
(PDF)
Figure S7 Impact of reference panel on sensitivity and
specificity. We constructed a reference panel in three different
ways: from 46 sequence data (Seq panel), from 46 sequence data
and the array data used to genotype the test sample (Seq and array
panel), and from 46 sequence data and Omni 2.5 data (Seq and
Omni panel). We then assessed sensitivity and specificity when the
test sample was called with all combinations of sequence and array
data. (a) a 381 European sample reference panel; (b) a 41
European sample reference panel; and (c) a 41 African sample
reference panel. We find that the use of array data on top of 46
sequence data to build the reference panel has a small but
significant effect on sensitivity for low coverage sequencing or
small reference panels.
(PDF)
Figure S8 Sensitivity gains from investment. Shown are
SensI values for all combinations of array and sequence data.
Points are colored according to the array data collected and
labeled with the sequence data collected. The x-axis plots SensD, a
measure of genotyping investment intrinsic to a technology. SensD
correlates, though not strictly, with cost. (a) 381 European sample
reference panel. (b) 41 European sample reference panel. (c) 41
African sample reference panel.
(PDF)
Figure S9 Specificity with and without imputation.
Shown is data analogous to Figure 2b but with SpecD in addition
to SpecI. (a) 381 European sample reference panel. (b) 41
European sample reference panel. (c) 41 African sample reference
panel.
(PDF)
Figure S10 Impact of no-call threshold on sensitivity
and specificity without imputation. Shown are SensD and
SpecD values, as computed in Figure 2a and Figure S9a, for
different Phred-scaled genotype quality thresholds; if the genotype
quality is X, the posterior probability of the most likely genotype is
1–102X. For our main analysis, we called genotypes only at sites
where the genotype quality exceeded 10. (a) No genotype quality
thresholds; calls at all sites where most likely genotype probability
exceeds 33.3%. (b) Genotype quality threshold of 10: calls at sites
where the most likely genotype probability exceeds 90%. (c)
Genotype quality threshold of 20: calls at sites where the most
likely genotype probability exceeds 99%.
(PDF)
Figure S11 Impact of no-call threshold on sensitivity
and specificity with imputation. Shown are numbers
analogous to Figure S10 but for SensI and SpecI rather than
SensD and SpecD. (a) No genotype quality thresholds. (b)
Genotype quality threshold of 10. (c) Genotype quality threshold
of 20.
(PDF)
Figure S12 Sensitivity and specificity at heterozygous
and homozygous variants. Shown are data analogous to
Figure 2ab but with sensitivity and specificity computed separately
for variants at which the test sample has a heterozygous and
homozygous genotype. (a) Heterozygous genotypes. (b) Homozy-
gous non-reference genotypes.
(PDF)
Figure S13 Sensitivity and specificity in coding regions.
Shown are data analogous to Figure 2ab but broken into metrics
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for coding and noncoding variants. (a) Coding variants. (b)
Noncoding variants.
(PDF)
Figure S14 Sensitivity and specificity by minor allele
frequency: 381 European sample reference panel. Shown
are data analogous to Figure 2c but with SpecI in addition to
SensI.
(PDF)
Figure S15 Impact of prior array data on sensitivity:
381 sample European reference panel. Shown are data
analogous to Figure 3 but with an additional array (Affy 500 k). (a)
All variants. (b) Variants with minor allele frequency (MAF)
between .5 and 5%. (c) Variants with MAF.5%.
(PDF)
Figure S16 Sensitivity and specificity at sites not on the
array: actual values. Shown is data analogous to Figure 4a but
with actual values rather than normalized values. Calls based on
sequence data (Seq) calls are plotted in red, joint (Joint) calls are
plotted in blue. The red bars differ in size because the sites
analyzed depend on the array. (a) 381 European sample reference
panel. (b) 41 European sample reference panel. (c) 41 African
sample reference panel.
(PDF)
Figure S17 Impact of additional sequence data on
sensitivity and specificity at sites on the array. We
evaluated joint calls from sequence and array data when different
fractions of samples had sequence data available; as in Figure 4b,
we called genotypes for a batch of 83 samples. We computed calls
with (blue) and without (red) haplotype phasing. For each SNP
array, we tested scenarios where no samples had sequence data
(0%), one sample had high coverage sequence data (1%), two
samples had high coverage sequence data (2%), 10%–50% of
samples had low coverage sequence data, all but the test sample
had low coverage sequence data (99%), and all samples had low
coverage sequence data (100%). The test sample had sequence
data only in the final case.
(PDF)
Figure S18 Sensitivity and specificity at sites on the
array by allele frequency. Sensitivity and specificity at sites on
each SNP array as a function of minor allele frequency. Joint calls
were made in the same manner as described in Figure 4b. Results
are stratified by SNP array and different colored lines represent
different data combinations: joint call SensI (blue), joint calls
SensD (cyan), array call SensI (green), and array call SensD (red).
(a) Sensitivity. (b) Specificity.
(PDF)
Figure S19 Impact of sequence data and phasing on
sensitivity and specificity for sites on the array. We
computed joint calls for 83 samples (as in Figure 4b) but in four
different ways: based on array data (Array only), based on array
data with haplotype phasing (Array+Phasing), based on array data
and sequence data without haplotype phasing (Array+Seq), and
based on array data and sequence data with haplotype phasing
(Joint).
(PDF)
Figure S20 Impact of new clusters and joint likelihoods
on sensitivity and specificity at sites on the chip. At sites
on the SNP array, joint calls have higher sensitivity and specificity
than array calls for two reasons: genotype likelihoods for the test-
sample are computed from both sequence and array data, and
genotype cluster locations are computed based on sequence data
and haplotype phasing (Figure 1, Figure S1). To quantify these two
contributions, we compared sensitivity and specificity for array
calls (Array only), for calls made from the joint likelihoods without
cluster re-estimation (Likelihoods only), for calls made from array
likelihoods but with cluster locations re-estimated from all data
(Cluster only), and for joint calls (Joint). We did not use haplotype
phasing to compute any genotype calls for this experiment. Joint
calls were made in the same manner as described in Figure 4b.
(PDF)
Figure S21 Analysis of SNPs initially classified as ‘‘false
positive’’. We identified 639 SNPs on the Metabochip
polymorphic based on sequence data but monomorphic based
on array data. Based on the joint calls, 127 SNPs are no-called and
therefore unresolved, 331 SNPs are polymorphic, and 181 SNPs
are monomorphic. The left plots show calls based on array data
(ovals represent genotype classes) and sequence data (outlines of
circles represent genotype classes); the right plots show joint calls
with colors and symbols as defined in Figure S1.
(PDF)
Figure S22 Genotype likelihoods of fragment-based
calling. (a) Mathematical formalism for fragment-based (rather
than read-based) SNP calling. The likelihood of a read pair given a
hypothesized genotype GTAB with alleles A and B is calculated
via a two-stage inference that weights the probability of each read
independently by the probability of a PCR (or other) error
occurring in the sequenced DNA fragment. In the above equation,
p refers to error rate of the fragment, f refers to the base in the
fragment, e refers to the error rate in the read, and b refers to the
base in the read. Thus, errors that occur during fragment
construction are counted only once, while errors that occur
during sequencing are counted independently. (b) Comparison of
the SNP genotype likelihood quality for GATK [27] SNP calls at
sites also on the Omni 2.5 array (chromosome 20 only). Ideally
calibrated likelihoods would follow the diagonal line. Fragment-
based likelihoods are more accurate at all confidence levels, but
the impact is most important for low confidence levels — which
correspond to points with less certain likelihoods.
(PDF)
Figure S23 Analysis of disputed SNPs. As described in the
text, we used our framework to resolve SNPs where array data
widely disagreed with 46 sequencing data. We classify disputes as
apparent sequence (or array) errors if the joint genotype calls
disagree with calls based on sequence (or array) data. (a) Example
disputed SNPs. The left plots show calls based on array data (ovals
represent genotype classes) and sequence data (outlines of circles
represent genotype classes); the right plots show joint calls with
colors and symbols as defined in Figure S1. (bc) We asked which
disputed SNPs were due to known or predicted error modes.
Plotted are values for six potential error modes, each stratified
across four classes of SNPs: agreed (sequence and array calls
disagree for ,10% of genotypes), disputed (sequence and array
calls disagree for $10% of genotypes), apparent array errors, and
apparent sequence errors. (b) Shown are the fraction of SNPs in
each class (1) with a DNA flanking region that occurs at multiple
genomic locations, (2) that lie within low complexity regions, and
(3) that lie within 50 bp of another SNP. Apparent array errors
have higher values for each of these metrics than apparent
sequence errors. (c) Shown are distributions over SNPs for (1) the
likelihood of forward/reverse DNA strand bias in sequence calls,
(2) the length of a neighboring homopolymer run, and (3) the
average (Phred-scaled) error rate of the reads supporting the
sequence call (higher values signify more confident SNP calls).
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Apparent sequence errors have higher values for each of these
metrics than apparent array errors.
(PDF)
Figure S24 Properties of resolved SNPs with greater
than 10% discordant genotypes. Distributions for all
potential error modes assessed on disputed SNPs, as in Figure
23bc.
(PDF)
Figure S25 Properties of resolved SNPs with greater
than 25% discordant genotypes. The same data as in Figure
S24 but for SNPs classified as disputed when array calls and
sequence calls disagree for more than 25% of sample genotypes.
(PDF)
Figure S26 Characterized disputed SNPs. We fit separate
distributions to each potential error mode for disputed and non-
disputed SNPs, as well as for each class of apparent error mode.
We considered a SNPs as characterized by an error mode
according to one of two criteria: if the error mode was binary, it
characterized a SNP if the SNP had value 1 for the error mode; if
the error mode was continuous, it characterized a SNP if the log of
the likelihood ratio (LOD) of the error mode distribution to the
non-disputed distribution exceeded two. (a) SNPs with greater
than 25% discordant genotypes. (b) SNPs with greater than 10%
discordant genotypes.
(PDF)
Text S1 Available as supporting supporting information are: (1)
calculations that show how previously described genotype calling
algorithms are similar in principle to the joint calling framework
when one or more of sequence reads, SNP array intensities, or
linkage disequilibrium is omitted; (2) sensitivity and specificity
calculations with a 41 sample European reference panel and a 41
sample African reference panel; and (3) investigation of the
increase of sensitivity with additional genotyping investment.
(PDF)
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